Astera Labs, Inc. (ALAB)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $38.77B
Last updated: Nov 17, 2026 at 11:05 AM ET
Astera Labs, Inc. (ALAB) Financials: Revenue, Profit and Cash Flow
Astera Labs reported revenue of $852.52M for the fiscal year ended Dec 31, 2025, up 115.1% from the year before. That year, net income was $219.13M with a net margin of 25.7%, operating cash flow was $319.31M and free cash flow was $281.76M. The quarter ended Sep 30, 2026 had revenue of $584.90M and net income of $182.94M.
Revenue and Margins
The operating margin was 20.3% in the fiscal year ended Dec 2025, the highest of the 4 years shown.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $852.52M | +115.1% | 75.7% | 20.3% | 25.7% |
| Dec 2024 | $396.29M | +242.2% | 76.4% | -29.3% | -21.1% |
| Dec 2023 | $115.79M | +45.0% | 68.9% | -25.5% | -22.7% |
| Dec 2022 | $79.87M | N/A | 73.5% | -75.4% | -73.0% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 100.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | $852.52M | $396.29M | $115.79M | $79.87M |
| Cost of revenue | $207.26M | $93.59M | $35.97M | $21.19M |
| Gross profit | $645.26M | $302.70M | $79.83M | $58.68M |
| Research and development | $304.00M | $200.83M | $73.41M | $73.71M |
| Operating income | $173.42M | -$116.07M | -$29.50M | -$60.19M |
| Net income | $219.13M | -$83.42M | -$26.26M | -$58.34M |
| EBITDA | N/A | N/A | -$29.37M | -$59.91M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $584.90M | $392.40M | $308.36M | $270.58M | $230.57M | $191.93M | $159.44M | $141.10M | $113.09M | $76.85M | $65.26M | $50.51M |
| Gross profit | $422.75M | $287.57M | $235.14M | $204.47M | $175.81M | $145.56M | $119.41M | $104.45M | $87.88M | $59.85M | $50.52M | $39.02M |
| Operating income | $179.06M | $89.25M | $61.83M | $66.96M | $55.41M | $39.77M | $11.29M | $144.00K | -$8.90M | -$24.35M | -$82.97M | $9.02M |
| Net income | $182.94M | $153.09M | $80.31M | $44.98M | $91.11M | $51.22M | $31.82M | $24.71M | -$7.59M | -$7.55M | -$93.00M | $14.32M |
Balance Sheet
As of Dec 2025, cash and equivalents of $167.61M were 11.0% of total assets of $1.53B, against total liabilities of $168.19M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total assets | $1.53B | $1.05B | $196.29M | $211.73M |
| Current assets | $1.36B | $1.01B | $185.81M | $206.00M |
| Cash and equivalents | $167.61M | $79.55M | $45.10M | $76.09M |
| Total liabilities | $168.19M | $89.71M | $38.87M | $297.02M |
| Short-term debt | N/A | $1.29M | $2.16M | $1.60M |
| Shareholder equity | $1.36B | $964.80M | -$97.70M | -$85.29M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.30B | $1.93B | $1.66B | $1.53B | $1.40B | $1.27B | $1.12B | $1.05B | $983.07M | $915.51M | $864.90M | $196.29M |
| Total liabilities | $300.87M | $205.80M | $165.27M | $168.19M | $129.45M | $135.69M | $80.13M | $89.71M | $93.45M | $70.26M | $56.12M | $293.99M |
| Cash and equivalents | $209.40M | $111.45M | $148.28M | $167.61M | $140.41M | $162.33M | $86.43M | $79.55M | $126.12M | $421.08M | $696.08M | $45.10M |
| Shareholder equity | $2.00B | $1.73B | $1.49B | $1.36B | $1.27B | $1.14B | $1.04B | $964.80M | $889.61M | $845.25M | $808.78M | -$97.70M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 88.2% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | $319.31M | $136.68M | -$12.72M | -$35.90M |
| Capital expenditures | $37.54M | $34.24M | $2.76M | $3.87M |
| Free cash flow | $281.76M | $102.43M | -$15.48M | -$39.77M |
| Share repurchases | $0 | $5.87M | $1.62M | $313.00K |
| Investing cash flow | -$241.47M | -$757.57M | -$17.77M | -$90.59M |
| Financing cash flow | $9.80M | $655.84M | -$502.00K | $151.67M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $179.20M | $87.68M | $74.60M | $95.27M | $78.17M | $135.37M | $10.50M | $39.70M | $63.51M | $29.81M | $3.65M | $14.40M |
| Capital expenditures | $45.31M | $20.47M | $7.59M | $18.69M | $12.29M | $2.02M | $4.54M | $15.45M | $16.70M | $1.32M | $3.42M | $1.01M |
| Free cash flow | $133.89M | $67.21M | $67.01M | $76.58M | $65.88M | $133.34M | $5.96M | $24.25M | $46.81M | $28.49M | $228.00K | $13.39M |
Frequently Asked Questions About ALAB
What is Astera Labs' annual revenue?
Astera Labs reported revenue of $852.52M for the fiscal year ended Dec 31, 2025.
How fast is Astera Labs' revenue growing?
Revenue was up 115.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 120.2%.
Is Astera Labs profitable?
Yes. Astera Labs reported net income of $219.13M for the fiscal year ended Dec 31, 2025, with a net margin of 25.7%.
How much free cash flow does ALAB generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $319.31M minus capital expenditures of $37.54M produced free cash flow of $281.76M.
How much debt does Astera Labs have?
The balance sheet dated Dec 31, 2025 reported cash and equivalents of $167.61M.
ALAB pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors